These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9304671)

  • 21. 'Genetics is not the issue': insurers on genetics and life insurance.
    Van Hoyweghen I; Horstman K; Schepers R
    New Genet Soc; 2005 Apr; 24(1):79-98. PubMed ID: 16552918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic information and life insurance risk classification and antiselection (1).
    Pokorski RJ
    J Insur Med; 1994-1995 Winter; 26(4):413-9. PubMed ID: 10150806
    [No Abstract]   [Full Text] [Related]  

  • 23. Genetic testing and insurance in Australia.
    Otlowski M; Barlow-Stewart K; Lacaze P; Tiller J
    Aust J Gen Pract; 2019 Mar; 48(3):96-99. PubMed ID: 31256467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UK insurers agree five year ban on using genetic tests.
    Mayor S
    BMJ; 2001 Nov; 323(7320):1021. PubMed ID: 11691749
    [No Abstract]   [Full Text] [Related]  

  • 25. Validation of genetic tests for insurance in UK.
    Kleinert S
    Lancet; 1998 Nov; 352(9140):1608. PubMed ID: 11660514
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic discrimination and insurance underwriting.
    Lowden JA
    Am J Hum Genet; 1992 Oct; 51(4):901-5. PubMed ID: 1415236
    [No Abstract]   [Full Text] [Related]  

  • 27. Your money or your life: will gene testing tell insurance companies anything about diseases they don't know already?
    Motluk A
    New Sci; 1997 Jan; 153(2065):12-3. PubMed ID: 11656586
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic tests for many rare diseases headed for orphan status.
    Kuska B
    J Natl Cancer Inst; 1997 Dec; 89(23):1748-9. PubMed ID: 9392610
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetic information and life insurance: a 'real' risk?
    Joly Y; Knoppers BM; Godard B
    Eur J Hum Genet; 2003 Aug; 11(8):561-4. PubMed ID: 12891375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should insurance pay for preventive services suggested by genetics?
    Lawrence J
    Manag Care; 1997 Jan; 6(1):42-6. PubMed ID: 10164532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic testing, adverse selection, and the demand for life insurance.
    Zick CD; Smith KR; Mayer RN; Botkin JR
    Am J Med Genet; 2000 Jul; 93(1):29-39. PubMed ID: 10861679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time for reassessment of use of all medical information by UK insurers.
    Thomson B
    Lancet; 1998 Oct; 352(9135):1216-8. PubMed ID: 9777856
    [No Abstract]   [Full Text] [Related]  

  • 33. Conversion of mortality ratios to a numerical rating classification for life insurance underwriting-revisited.
    Singer RB
    J Insur Med; 2004; 36(3):228-33. PubMed ID: 15495438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. msJAMA. Genomics in medicine and public health: role of cost-effectiveness analysis.
    Goldie SJ; Levin AR
    JAMA; 2001 Oct; 286(13):1637-8. PubMed ID: 11585493
    [No Abstract]   [Full Text] [Related]  

  • 35. Community concerns about genetic discrimination in life insurance persist in Australia: A survey of consumers offered genetic testing.
    Tiller J; Bakshi A; Dowling G; Keogh L; McInerney-Leo A; Barlow-Stewart K; Boughtwood T; Gleeson P; Delatycki MB; Winship I; Otlowski M; Lacaze P
    Eur J Hum Genet; 2024 Mar; 32(3):286-294. PubMed ID: 37169978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A look at the possible impact of new genetic technology on the life insurance industry.
    Necessary P
    J Insur Med; 1995-1996 Winter; 27(3):207-13. PubMed ID: 10160223
    [No Abstract]   [Full Text] [Related]  

  • 37. Conversion of mortality ratios to a numerical rating classification for life insurance underwriting. 1988.
    Singer RB
    J Insur Med; 2004; 36(3):234-41. PubMed ID: 15495439
    [No Abstract]   [Full Text] [Related]  

  • 38. The Added Value of Medical Testing in Underwriting Life Insurance.
    Bronsema J; Brouwer S; de Boer MR; Groothoff JW
    PLoS One; 2015; 10(12):e0145891. PubMed ID: 26716827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of genetic testing: discrimination in life insurance and future directions.
    Mould A
    J Law Med; 2003 May; 10(4):470-87. PubMed ID: 12852320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term care insurance underwriting: understanding eventual claims experience.
    Temkin-Greener H; Mukamel DB; Meiners MR
    Inquiry; 2000-2001 Winter; 37(4):348-58. PubMed ID: 11252445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.